Objective: Breast cancer is one of the most common cancers affecting women. Both physicians and patients have concerned about breast cancer survivability. Many researchers have studied the breast cancer survivability applying artificial nerural network model (ANN). Usually ANN model outperformed in classification of breast cancer survivability than other models such as logistic regression, Bayesian network (BN), or decision tree models. However, physicians in the fields hesitate to use ANN model, because ANN is a black-box model, and hard to explain the classification result to patients. In this study, we proposed a hybrid model with a degree of the accuracy and interpretation by combining the ANN for accuracy and BN for interpretation. Methods: We developed an artificial neural network, a Bayesian network, and a hybrid Bayesian network model to predict breast cancer prognosis. The hybrid model combined the artificial neural network and the Bayesian network to obtain a good estimation of prognosis as well as a good explanation of the results. The National Cancer Institute's SEER program public-use data were used to construct and evaluate the proposed models. Nine variables, which are clinically acceptable, were selected for input to the proposed models' nodes. A confidence value of the neural network served as an additional input node to the hybrid Bayesian network model. Ten iterations of random subsampling were performed to evaluate performance of the models. . The known risk factors are age at diagnosis, age of menarche, genetic risk, and family history [3] [4] [5] [6] . The most widely accepted prognostic factor for breast cancer is the American Joint Commission on Cancer (AJCC) staging system based on the TNM system (T, tumor; N, node; M, metastasis) [7] [8] [9] [10] [11] . The Nottingham prognosis index is a grading system that incorporates the evaluation of tumor size, stage of disease, and tumor grade 12)13)
. The known risk factors are age at diagnosis, age of menarche, genetic risk, and family history [3] [4] [5] [6] . The most widely accepted prognostic factor for breast cancer is the American Joint Commission on Cancer (AJCC) staging system based on the TNM system (T, tumor; N, node; M, metastasis) [7] [8] [9] [10] [11] . The Nottingham prognosis index is a grading system that incorporates the evaluation of tumor size, stage of disease, and tumor grade 12)13) . Recently, molecular biologic markers, such as the estrogen receptor, progesterone receptor, and HER-2/neu, have become important prognostic factors [14] [15] [16] .
Several studies have reported on breast cancer prognosis prediction using data mining techniques. Burke et al. constructed an artificial neural network (ANN) model using TNM variables, demographic variables, and anatomic variables in the prediction of 10-year survival of breast cancer 17) . They used 6,787 cases of the National Cancer Institute's Surveillance, Epidemiology, and End Results (SEER) breast carcinoma data set (1977) (1978) (1979) (1980) (1981) (1982) . The ANN model achieved a superior prediction accuracy of 73.0%, compared to that of 69.2% for the TNM staging system.
Choi constructed an ANN model for breast cancer screening using 1143 Korean subjects (case 272, control 871). The classification performance of the model was 0.76, sensitivity 0.72 and specificity 0.71 18) . Lee compared various predictive modeling techniques to predict the breast cancer occurance (not prognosis) by using Korean data obtained from 209 subject (109 patients and 100 controls).
The AUC of the proposed Naïve Bayes model was 0.90, and it outperformed than other various Bayesian network models or regression models 19) .
Lundin et al. compared logistic regression and ANN models for survival estimation in 951 breast cancer cases 20) . Eight variables were entered as input to the network, including tumor size, axillary node, histologic type, mitotic count, nuclear pleomorphism, tubule formation, tumor necrosis, and age. The area under the curve (AUC) of the ANN was 0.909 and that of logistic regression was 0.879.
Delen et al. compared ANN, decision tree, and logistic regression techniques for breast cancer survival estimation using the SEER data set (1973-2000) 21) . Twenty variables were used in the prediction models. The decision tree and ANN were superior to logistic regression (accuracy: 93.6%, 91.2%, and 89.2%, respectively).
Generally, ANN shows good estimation power for breast cancer prognosis. ANN has the advantage of a fast response with higher accuracy and real-time model modification.
Nonetheless, a major disadvantage of neural networks stems from difficulties in their representation of knowledge.
Acquired knowledge in the form of nodes and weighted links cannot be interpreted easily, and the system does not explain the result 22) .
The Bayesian network (BN) is a probabilistic model that consists of dependency structure and local probability. It uses prior probability in the prediction of dependent variables.
Usually, the structure of the network is constructed by domain experts based on their medical training and experience with previous cases. The probabilities are calculated using statistics from cases. The BN model is transparent and can be more attractive to clinicians because the influences and relations of the nodes are visualized through graphical models and the resulting decision is represented with a belief probability.
We propose a hybrid BN model using a confidence value of the ANN output node to predict 5-year survival rates for breast cancer. With the same input nodes, an ANN model and a BN model are constructed independently. The confidence value of the ANN output node is presented to the BN model as an additional input node. As a result, the hybrid BN model uses the confidence value of the ANN output node as an additional input node. The sensitivity, specificity, accuracy and AUC of the three models are compared for performance evaluation.
. Methods Ⅱ
In order to develop the models, we adopted the general data mining process: 1) cleaning and integration, 2) selection and transformation, 3) data mining, and 4) evaluation. At the first and second stages, we performed the data cleaning and variable selection by using statistic summaries. We chosen Artificial neural network, Bayesian Network, and hybrid algorithms for predicting the breast cancer survivability and performed data mining. Finally, we evaluated the result models with accuracy, sensitivity, specificity, and AUC. As the following, we describe each stage in detail.
Data collection
We used the SEER program (www.seer.cancer.gov) public-se data and 'clinical extension of tumor' were used to derive each stage (T, N, and M). Of the TNMs, T1, T2, T3, and M0 were removed from input nodes because of their weak discriminative power, and Tis, T4, N0, N1, N2, N3 and M1
were added as input nodes (Table 1, Table 2 ). Although some continuous variables such as clinical extension of the tumor, site-specific surgery, and scope of regional lymph node surgery are not actually continuous variables in nature, they were treated as continuous values as they were arranged in order of disease severity.
To develop models for predicting survival in an incidence of breast cancer, the target variable 'Survival' defined as a 'patient who survives more than 60 months after the date of diagnosis'. After data cleansing and data preparation, we obtained the final data set with 294,275 records and 15 variables (seven primary variables, seven derived variables, and one target variable). record is presented to the network during training. To avoid the possibility of overfitting the data, we randomly split the training data into two sets, with 50% for training and 50% for monitoring.
Prediction models
To discriminate the relative importance of input nodes, sensitivity analysis was performed for each neural network model. We calculated the sensitivity of an input node by varying the value of that input value for each record, and determined the difference between the maximum and minimum outputs. This maximum difference was calculated for every record, and then averaged. .
To develop a Bayesian network, a network structure must first be constructed. Two ways can be used to build the topology of the Bayesian network. The first involves using domain experts who usually have a good grasp of the direct conditional dependencies in the domain to develop the structure of the Bayesian network. The second involves using structure learning algorithms, such as genetic algorithms, to construct the network topology from training data. In our case, the network structure was designed by expert opinion and extensive repeat evaluations of model accuracy. Fourteen dependent variables and one target variable were also used for the Bayesian network model.
All of the continuous variables were discretized. The selected variables and their possible states in our network are summarized in Table 1, Table 2 .
In addition to the network topology, it is necessary to specify a CPT for each node. When all variables are fully observable and the structure of the network is known, the CPT can be estimated directly using statistics from the training data.
To combine the good estimation power of ANN with the Confidence was calculated as c = 2|0.5-o|, where o is the output activation. Figure 1 illustrates the network topology. After the BN and HBN(Hybrid Bayesian Network) were constructed, they were applied to the test data. The classification method was based on maximum a posteriori (MAP) method which achieves the minimum error rate for all possible classifiers. NETICA (version 3.19; Norsys Software Corp, Vancouver, Canada) was used for Bayesian network construction and performance evaluation.
. Results Ⅲ
In total, 294,275 records were selected for this study. Records prior to 1988 were removed because of the absence of AJCC stage observations. The mean age at diagnosis was 60.96 years (SD: 14.0). The 'site-specific surgery' variable had 162,500 (55.2%) valid records (131,775 records missing). The 'scope of regional lymph node surgery' variable had 110,204 (37.4%) valid records (184,071 records missing). For the AJCC stage, the number of patients with stage 0 was 53,689 (18.2%), the number of patients with stage I was 11,835 (40.3%), the number of patients with stage IIA was 62,104 (21.1%), the number of patients with stage IIB was 30,854 (10.5%), the number of patients with stage IIIA was 8,819 (3.0%), the number of patients with stage IIIB was 8,026 (2.7%), and the number of patients with stage IV was 12,248 (4.2%). The number of primary tumors ranged from 1 to 9, but most was between 1 and 3 (99.6%).
Performance of the proposed models was evaluated for each ten-iteration sequence of the validation process ( Table  3 ). The ANN model achieved the highest prediction accuracy of 88.8% with a sensitivity of 93.7% and a specificity of 85.4%. The hybrid Bayesian network model achieved a prediction accuracy of 87.2% with a sensitivity of 0o=[93.3% and a specificity of 83.1%. Results of the hybrid BN model were very similar to those of the ANN model. However, the BN alone model achieved a prediction accuracy of 70.9% with a sensitivity of 88.5% and a specificity of 58.3%. For the AUCs, the hybrid BN model achieved the highest value of 0.935, whereas the corresponding values of ANN and BN were 0.930 and 0.813, respectively (Fig. 2) . The hybrid BN model had larger SD in sensitivity, specificity and accuracy than ANN or BN model, however the SD of AUC was not differ significantly. Sensitivity analysis for each input variable was performed in the ANN model formulation (Figure 3) . The 'scope of regional lymph node surgery' variable had the highest relative importance (mean 0.685, SD 0.109). It was followed by 'site-specific surgery' (mean 0. However, the proposed hybrid BN model has some limitations. Both the ANN and hybrid BN models are similar in AUC, therefore the classification power of the hybrid BN may be largely originated form ANN rather than BN. Therefore, the explain power of the BN may not representative of the nature. There are replication of nodes in both the ANN and BN, which composing the hybrid BN model, therefore there may some waste of computing power. However, the authors designed the model to use the same nodes in both ANN and hybrid BN model. As the same nodes of the ANN are used in the hybrid model again, it may possible that the posterior probability of the network may represent the status of the decision from the ANN model. It seems that further study to measures the effect of the node from ANN confidence value may be helpful to generalize the porposed hybrid BN model.
We tried to develop a high-performance and easy to Accuracies of models were high (93.6%, 91.2%, and 89.2%, respectively). However, in the tenfold cross-validation, 90% of the data set was used to train the model and only 10% is used to test the model. Furthermore, because the data set cleaned from the SEER data, variables, and performance measures in Delen's study differ from ours, it is difficult to directly compare the results. We focused our attention on records having an AJCC stage 3rd edition field. Data records (1973) (1974) (1975) (1976) (1977) (1978) (1979) (1980) (1981) (1982) (1983) (1984) (1985) (1986) (1987) without the AJCC stage 3rd edition were thus excluded. Given that improvements in breast cancer treatments will continue and new risk factors will be uncovered, it is practical to construct models using the most recent data set. We also conducted a sensitivity analysis on the ANN model to gain the effects of variables on breast cancer survivability. The 'scope of regional lymph node surgery' variable was the most important, which was followed by 'site-specific surgery,' 'extension of tumor,' and 'AJCC stage'. Hormone receptor expression is known to be an important prognostic factor of breast cancer. We tried to use estrogen receptor (ER) and progesterone receptor (PR) information as input nodes, but sensitivity analysis revealed that the relative importance of ER and PR were very low (<0.06).
Furthermore, pilot evaluation of the model also showed little difference in performance (data not shown). Records containing valid values for ER and PR accounted for 62.7%
and 55.8% of the data, respectively. The SEER data set does not contain HER-2/neu information, which is associated with breast cancer prognosis 16) . In the future, if the SEER data set includes new prognostic factors such as HER-2/neu and enough of the data set is prepared, additional analysis may be necessary.
We combined an ANN model and a Bayesian network model to produce a hybrid Bayesian network model for breast cancer survival prediction. In the experiments, the hybrid model and the ANN model outperformed the Bayesian network model. The hybrid model could provid an explanation of the results through the network topology.
Although our approach is not the most accurate in the prediction of breast cancer survivability, we believe that our hybrid method could encourage the development of other useful prediction methods in the medical domain.
(3) Measures of performance
Ten iterations of the random subsampling method were used to construct and estimate the performance of the models. The given data were randomly partitioned into two independent sets, a training set and a test set. In this study, half of the data were allocated to the training set, and the remaining half were allocated to the test set. Each model was constructed using the training set, and the remaining test set was used to evaluate model performance. This validation cycle was repeated 10 times. Results were averaged to produce a single estimation of performance for each model. 
